Chronic phase chronic patients receive oral imatinib mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Philadelphia Chromosome K562 Cells Cell Line, Tumor Chromosomes, Human, Pair 9 Neoplastic Stem Cells Bone Marrow Hematopoietic Stem Cells Cells, Cultured Myeloid Progenitor Cells

Organisms1

Trypanosoma cruzi

Diseases32

Chronic Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Blast Crisis Philadelphia Chromosome Hypereosinophilic Syndrome Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Hypopigmentation Leukemia, Myeloid, Accelerated Phase Gastrointestinal Neoplasms Dermatofibrosarcoma Mastocytosis, Systemic Fibromatosis, Aggressive Neoplasm, Residual Disease Progression Chagas Disease Recurrence Lichenoid Eruptions Precursor Cell Lymphoblastic Leukemia-Lymphoma Chagas Cardiomyopathy Leukemia Primary Myelofibrosis Chromosome Aberrations Scleroderma, Systemic Histiocytoma, Malignant Fibrous Acute Disease Disease Models, Animal Fibrosis Graves Ophthalmopathy Myeloproliferative Disorders Leukemia, Myeloid

Chemicals and Drugs34

Benzamides Piperazines Pyrimidines Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor alpha Receptor, Platelet-Derived Growth Factor beta Protein-Tyrosine Kinases Proto-Oncogene Proteins c-abl Harringtonines Thiazoles Interferon-alpha Receptors, Platelet-Derived Growth Factor Enzyme Inhibitors Pregnatrienes Proto-Oncogene Proteins c-sis Hydroxyurea mRNA Cleavage and Polyadenylation Factors RNA, Messenger Antigens, CD34 Ketones Furans Pyrroles Rifabutin Cytarabine STAT5 Transcription Factor Platelet-Derived Growth Factor Stem Cell Factor Neoplasm Proteins Indoles Busulfan Oncogene Proteins, Fusion

Analytical, Diagnostic and Therapeutic Techniques and Equipment27

Treatment Outcome Cytogenetic Analysis Remission Induction Disease-Free Survival Drug Approval Survival Analysis Prognosis Transplantation, Homologous Administration, Oral Survival Rate Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Treatment Failure Reverse Transcriptase Polymerase Chain Reaction In Situ Hybridization, Fluorescence Salvage Therapy Follow-Up Studies Blood Cell Count Hematopoietic Stem Cell Transplantation Combined Modality Therapy Immunohistochemistry Bone Marrow Transplantation Disease Models, Animal Inhibitory Concentration 50 Karyotyping Blotting, Western Neoadjuvant Therapy

Psychiatry and Psychology1

Phenomena and Processes17

Genes, abl Drug Resistance, Neoplasm Philadelphia Chromosome Dose-Response Relationship, Drug Time Factors Gene Expression Regulation, Leukemic Apoptosis Cell Proliferation Mutation Chromosomes, Human, Pair 9 Phosphorylation Drug Synergism Blood Cell Count Chromosome Aberrations Signal Transduction Inhibitory Concentration 50 Cell Survival

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Information Science1

Health Care7

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Treatment Failure Follow-Up Studies United States Food and Drug Administration

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Benzamides Piperazines Chronic Disease Pyrimidines Schizophrenia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Fusion Proteins, bcr-abl Leukemia, Myeloid, Chronic-Phase Treatment Outcome Antineoplastic Agents Proto-Oncogene Proteins c-kit Protein Kinase Inhibitors Blast Crisis Receptor, Platelet-Derived Growth Factor alpha Genes, abl Cytogenetic Analysis Drug Resistance, Neoplasm Receptor, Platelet-Derived Growth Factor beta Philadelphia Chromosome Protein-Tyrosine Kinases Hypereosinophilic Syndrome Proto-Oncogene Proteins c-abl K562 Cells Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Hypopigmentation Leukemia, Myeloid, Accelerated Phase Gastrointestinal Neoplasms Remission Induction Harringtonines Thiazoles Interferon-alpha Receptors, Platelet-Derived Growth Factor Dermatofibrosarcoma Enzyme Inhibitors Disease-Free Survival Mastocytosis, Systemic Drug Approval Dose-Response Relationship, Drug Pregnatrienes Cell Line, Tumor Time Factors Fibromatosis, Aggressive Cytogenetics Proto-Oncogene Proteins c-sis Survival Analysis Hydroxyurea Prognosis Neoplasm, Residual Gene Expression Regulation, Leukemic Apoptosis Transplantation, Homologous Disease Progression Chagas Disease Administration, Oral Survival Rate Recurrence Cell Proliferation Mutation Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Chromosomes, Human, Pair 9 Neoplastic Stem Cells Treatment Failure Lichenoid Eruptions mRNA Cleavage and Polyadenylation Factors Reverse Transcriptase Polymerase Chain Reaction Bone Marrow Phosphorylation In Situ Hybridization, Fluorescence Salvage Therapy Trypanosoma cruzi Drug Synergism Follow-Up Studies Blood Cell Count RNA, Messenger Antigens, CD34 Precursor Cell Lymphoblastic Leukemia-Lymphoma Ketones Hematopoietic Stem Cell Transplantation Chagas Cardiomyopathy Furans Leukemia Pyrroles United States Food and Drug Administration Rifabutin Primary Myelofibrosis Cytarabine Chromosome Aberrations STAT5 Transcription Factor Platelet-Derived Growth Factor Signal Transduction Combined Modality Therapy Hematopoietic Stem Cells Immunohistochemistry Cells, Cultured Scleroderma, Systemic Bone Marrow Transplantation Histiocytoma, Malignant Fibrous Stem Cell Factor

No FAQ available that match "chronic phase chronic patients receive oral imatinib mesylate"